Dore, M., Filoche, S., Danielson, K., & Henry, C. (2021). Characterisation of levonorgestrel-resistant endometrial cancer cells. Cancer Management & Research, 13, 7871-7884. doi: 10.2147/CMAR.S327381

Journal - Research Article

Dore, M., Filoche, S., Danielson, K., & Henry, C. (2021). Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response? Gynecologic Oncology Reports. Advance online publication. doi: 10.1016/j.gore.2021.100732

Journal - Research Article

Henry, C. E., Phan, K., Orsman, E. J. O., Kenwright, D., Thunders, M. C., & Filoche, S. K. (2021). Molecular profiling of endometrial cancer: An exploratory study in Aotearoa, New Zealand. Cancers, 13(22), 5641. doi: 10.3390/cancers13225641

Journal - Research Article

Henry, C., Ekeroma, A., Dowell, A., & Filoche, S. (2021). 'The horror stories put me off!': Exploring women's acceptability of the Levonorgestrel IntraUterine System (LNG-IUS) for endometrial protection. Journal of Primary Health Care, 13(1), 55-62. doi: 10.1071/HC20105

Journal - Research Article

Henry, C., Ekeroma, A., & Filoche, S. (2020). Barriers to seeking consultation for abnormal uterine bleeding: Systematic review of qualitative research. BMC Women's Health, 20, 123. doi: 10.1186/s12905-020-00986-8

Journal - Research Article

Henry, C., Jefferies, R., Ekeroma, A., & Filoche, S. (2020). Beyond the numbers-understanding women's experiences of accessing care for abnormal uterine bleeding (AUB): A qualitative study. BMJ Open, 10, e041853. doi: 10.1136/bmjopen-2020-041853

Journal - Research Article

Lu, M., Henry, C. E., Lai, H., Khine, Y. Y., Ford, C. E., & Stenzel, M. H. (2019). A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles. Biomaterials Science, 7, 1652-1660. doi: 10.1039/c8bm01326h

Journal - Research Article

Cortesi, M., Llamosas, E., Henry, C. E., Kumaran, R.-Y. A., Ng, B., Youkhana, J., & Ford, C. E. (2018). I-AbACUS: A reliable software tool for the semi-automatic analysis of invasion and migration transwell assays. Scientific Reports, 8, 3814. doi: 10.1038/s41598-018-22091-5

Journal - Research Article

Henry, C. E., Llamosas, E., Daniels, B., Coopes, A., Tang, K., & Ford, C. E. (2018). ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecologic Oncology, 148(3), 576-584. doi: 10.1016/j.ygyno.2018.01.025

Journal - Research Article

Henry, C. E., Emmanuel, C., Lambie, N., Loo, C., Kan, B., Kennedy, C. J., … Ford, C. E. (2017). Distinct patterns of stromal and tumor expression of ROR1 and ROR2 in histological subtypes of epithelial ovarian cancer. Translational Oncology, 10(3), 346-356. doi: 10.1016/j.tranon.2017.01.014

Journal - Research Article

Henry, C., Hacker, N., & Ford, C. (2017). Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis. Oncotarget, 8(68), 112727-112738. doi: 10.18632/oncotarget.22559

Journal - Research Article

Ma, S. S. Q., Henry, C. E., Llamosas, E., Higgins, R., Daniels, B., Hesson, L. B., … Ford, C. E. (2017). Validation of specificity of antibodies for immunohistochemistry: The case of ROR2. Virchows Archiv, 470(1), 99-108. doi: 10.1007/s00428-016-2019-5

Journal - Research Article

Henry, C. E., Llamosas, E., Djordjevic, A., Hacker, N. F., & Ford, C. E. (2016). Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer. Oncogenesis, 5, e226. doi: 10.1038/oncsis.2016.32

Journal - Research Article

Henry, C., Llamosas, E., Knipprath-Meszaros, A., Schoetzau, A., Obermann, E., Fuenfschilling, M., … Ford, C. (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget, 6, 40310-40326. doi: 10.18632/oncotarget.5643

Journal - Research Article

Henry, C., Quadir, A., Hawkins, N. J., Jary, E., Llamosas, E., Kumar, D., … Ford, C. E. (2015). Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Journal of Cancer Research & Clinical Oncology, 141, 243-254. doi: 10.1007/s00432-014-1824-y

Journal - Research Article

Ford, C. E., Punnia-Moorthy, G., Henry, C. E., Llamosas, E., Nixdorf, S., Olivier, J., … Heinzelmann-Schwarz, V. (2014). The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecologic Oncology, 134(2), 338-345. doi: 10.1016/j.ygyno.2014.06.004

Journal - Research Article

Kanagasabai, P. S., Filoche, S., Grainger, R., Henry, C., & Hay-Smith, J. (2022). Interventions to improve access to care for abnormal uterine bleeding: A systematic scoping review. International Journal of Gynecology & Obstetrics. Advance online publication. doi: 10.1002/ijgo.14224

Journal - Research Other

Clarricoats, G., Ormandy, J., Henry, C., Meikle, A., & Filoche, S. (2021). COVID-19 vaccination in pregnancy: Time to act, time to advocate. Australian & New Zealand Journal of Obstetrics & Gynaecology, 61(6), E30. doi: 10.1111/ajo.13461

Journal - Research Other

Henry, C., Filoche, S., Thunders, M., Kenwright, D., & Ekeroma, A. (2019). Reflection on the current status of endometrial cancer in New Zealand. Australian & New Zealand Journal of Obstetrics & Gynaecology, 59, 874-876. doi: 10.1111/ajo.13057

Journal - Research Other

Ford, C. E., Henry, C., Llamosas, E., Djordjevic, A., & Hacker, N. (2016). Wnt signalling in gynaecological cancers: A future target for personalised medicine? Gynecologic Oncology, 140, 345-351. doi: 10.1016/j.ygyno.2015.09.085

Journal - Research Other